Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection.

Viruses
Teresa I NgChristine Collins

Abstract

Glecaprevir (an NS3/4A protease inhibitor) and pibrentasvir (an NS5A inhibitor) are potent and pangenotypic hepatitis C virus (HCV) direct-acting antivirals. This report describes the baseline polymorphisms and treatment-emergent substitutions in NS3 or NS5A detected in samples from HCV genotype 1-infected patients receiving 3-day monotherapy of glecaprevir or pibrentasvir, respectively. None of the NS3 polymorphisms detected in the 47 baseline samples collected prior to glecaprevir monotherapy conferred reduced susceptibility to glecaprevir. The NS3 A156T substitution, which conferred resistance to glecaprevir but had low replication efficiency, emerged in one genotype 1a-infected patient among the 35 patients with available post-baseline sequence data. Baseline NS5A polymorphisms were detected in 12 of 40 patients prior to pibrentasvir monotherapy; most polymorphisms were single-position NS5A amino acid substitutions that did not confer resistance to pibrentasvir. Among the 19 patients with available post-baseline NS5A sequence data, 3 had treatment-emergent NS5A substitutions during pibrentasvir monotherapy. All treatment-emergent NS5A substitutions were linked multiple-position, almost exclusively double-position, substitut...Continue Reading

References

Aug 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert A FridellMin Gao
Sep 22, 2012·Journal of Medical Virology·M Michele ManosNorah J Shire
Dec 27, 2012·JAMA : the Journal of the American Medical Association·Adriaan J van der MeerHarry L A Janssen
Feb 7, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Dennis HernandezFiona McPhee
Mar 19, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fiona McPheeDavid Gardiner
Apr 10, 2013·Journal of Hepatology·Jean-Michel Pawlotsky
Oct 12, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donald B SmithPeter Simmonds
Mar 29, 2014·ACS Medicinal Chemistry Letters·Ann D Kwong
Jul 30, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jane P MessinaEleanor Barnes
Oct 1, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anita Y M HoweNiloufar Mobashery
Dec 3, 2014·Antimicrobial Agents and Chemotherapy·Tami Pilot-MatiasChristine Collins
Dec 3, 2014·Antimicrobial Agents and Chemotherapy·Preethi KrishnanTami Pilot-Matias
Jun 23, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Erik LontokVeronica Miller
Aug 26, 2015·Antimicrobial Agents and Chemotherapy·Rong LiuAnita Y M Howe
Jan 5, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Tarik AsselahPatrick Marcellin
Feb 15, 2017·Antimicrobial Agents and Chemotherapy·Teresa I NgChristine Collins
Mar 21, 2017·Annals of Internal Medicine·Oluwaseun Falade-NwuliaMark S Sulkowski
Jun 24, 2017·Gastroenterology·Fasiha KanwalHashem B El-Serag
Oct 12, 2017·The New England Journal of Medicine·Edward GaneFederico J Mensa
Dec 2, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patrick R HarringtonLisa K Naeger
Jan 25, 2018·The New England Journal of Medicine·Stefan ZeuzemFederico J Mensa

❮ Previous
Next ❯

Citations

Sep 4, 2020·Journal of Medicinal Chemistry·John T RandolphDavid A DeGoey

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Clinical Trials Mentioned

NCT01995071

Software Mentioned

Prism

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.